Skip to main content
. 2019 Jan 11;98(2):e13981. doi: 10.1097/MD.0000000000013981

Figure 1.

Figure 1

Assembly of cohort of Chinese adults with chronic kidney disease (CKD) initiating erythropoiesis-stimulating agent (ESA) therapy.